Congress demands real-time alerts on infant formula contamination
H.R. 7867 — Infant Formula Safety Modernization Act of 2026 · Filed by Rosa DeLauro (D-CT) · 44 cosponsors · Introduced Mar 9, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires infant formula manufacturers to test their facilities and finished products for dangerous pathogens (including botulism) and report positive results to the FDA within one business day. The FDA must then notify Congress within one business day of any positive test or serious inspection failure. The bill mandates the FDA issue detailed testing and inspection standards within 90 days.
Why we flagged it
The bill's operative mechanism is a direct regulatory mandate requiring manufacturers to test for pathogens and report results to the FDA and Congress. It is a safety-driven accountability measure, not a market intervention or subsidy.
What the text implies
- Congressional notification requirement creates a real-time legislative oversight channel for infant formula safety crises, potentially enabling faster legislative response than traditional FDA-only reporting.
- One-business-day reporting deadline for positive tests may accelerate market withdrawal of contaminated batches, reducing consumer exposure window but potentially creating supply-chain volatility if multiple facilities report simultaneously.
- Mandatory testing of Zones 2 and 3 (non-contact surfaces) may reveal environmental contamination patterns earlier than finished-product testing alone, improving preventive detection but increasing operational burden on manufacturers.
- FDA must develop a definitive pathogen list within 90 days; any pathogen omitted from the initial list creates a regulatory gap until amendment, potentially leaving some risks unmonitored during the transition period.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Ordinary citizens—especially parents of infants—gain direct protection through mandatory pathogen testing, faster detection of contamination, and congressional oversight of safety failures. The bill imposes no new costs on consumers and strengthens accountability for a product critical to infant health and survival.
Named in the bill
FDA (Food and Drug Administration), Secretary of Health and Human Services, Commissioner of Food and Drugs, House Committee on Energy and Commerce, Senate Committee on Health, Education, Labor, and Pensions, Infant formula manufacturers, Clostridium botulinum
Where it stands
44 cosponsors: 40 Democrats, 4 Republicans.
- Mar 9, 2026 — Introduced · Congress.gov: “Introduced in House”
- Mar 9, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
3 lobbying clients named this bill on 3 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $664,000 in lobbying spend. A filing names 27 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 61% of bills with at least one filing.
Rosa DeLauro, the sponsor, reported $624,463 in PAC receipts in the 2026 cycle.
- Food Marketplace Inc — $584,000 on 1 filing
- Bobbie Baby, Inc. — $50,000 on 1 filing
- Mondelez International, Inc. — $30,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (4,216 characters) on Aug 20, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress demands real-time alerts on infant formula contamination” QuorumCivic. https://share.quorumcivic.app/bill/119/hr7867 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.